Crossmark

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life

Published Online: 2020-06-25

Published Print: 2020-06

Authors

Longato, Enrico

Di Camillo, Barbara https://orcid.org/0000-0001-8415-4688
Sparacino, Giovanni https://orcid.org/0000-0002-3248-1393
Gubian, Lorenzo

Avogaro, Angelo

Fadini, Gian Paolo https://orcid.org/0000-0002-6510-2097
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04184947 at ClinicalTrials.gov

Documents that mention this clinical trial

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
https://doi.org/10.1136/bmjdrc-2020-001451
Funding

Funding for this research was provided by:

Italian Ministry for Education ("Departments of Excellence" (Law 232/2016))
License Information

License valid from 2020-06-23

Document is current